FDA Inspection 999784 — Evaric Pharmaceuticals Inc.

Evaric Pharmaceuticals Inc. — FEI 3013061208

The FDA completed an inspection of Evaric Pharmaceuticals Inc. on Feb 7, 2017 in Hauppauge, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 7, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hauppauge, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.